Redhill Biopharma Other Current Liabilities

Redhill Biopharma (RDHL) currently reports a other current liabilities of $13M as of December 2025. That compares with $14M in the prior-year period — down 9.8% year over year. Use the charts on this page to explore Redhill Biopharma's other current liabilities history and peer comparisons.

Redhill Biopharma's other current liabilities decreased from $14M to $13M — a 9.8% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Redhill Biopharma reported $13M in other current liabilities as of December 2025. That compares with $14M in the prior-year period — down 9.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Redhill Biopharma, and consider following RDHL for alerts when major investors trade the stock.

Redhill Biopharma is classified in the Healthcare sector. On other current liabilities, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RDHL with unrelated industries.